Shunsuke Hamada

CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study

Shunsuke Hamada, Naohisa Futamura, K. Ikuta et al. · PLoS ONE · 2014 · 52 citations · Full text

Pathology, Cancer Biology, Tumor Biology +16

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn’s disease

Katsuyoshi Matsuoka, Shunsuke Hamada, Mikiko Shimizu et al. · PLoS ONE · 2018 · 34 citations · Full text

Chronic Inflammatory Diseases, Immunology, Gastroenterology +18

Heat-stimuli-enhanced osteogenesis using clinically available biomaterials

Takehiro Ota, Yoshihiro Nishida, K. Ikuta et al. · PLoS ONE · 2017 · 30 citations · Full text

Tissue Engineering, Engineering, Alginate Gel +20

Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis

Takehiro Ota, Hiroshi Urakawa, Eiji Kozawa et al. · Tumor Biology · 2015 · 27 citations · Full text

Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study

Hiroshi Koike, Yoshihiro Nishida, Kei Kohno et al. · Human Pathology · 2018 · 26 citations

Fibrosis, Medicine, Surgical Pathology +11